The Goldman Sachs Group Has Lowered Expectations for Tandem Diabetes Care (NASDAQ:TNDM) Stock Price
Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its price objective trimmed by The Goldman Sachs Group from $42.00 to $24.00 in a research report released on Monday morning,Benzinga reports. The brokerage currently has a neutral rating on the medical device company’s stock. Other equities analysts also recently issued research reports about the company. Morgan […]
Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its price objective trimmed by The Goldman Sachs Group from $42.00 to $24.00 in a research report released on Monday morning,Benzinga reports. The brokerage currently has a neutral rating on the medical device company’s stock. Other equities analysts also recently issued research reports about the company. Morgan […]
